Amylyx Pharmaceuticals (AMLX) Stock Price & Analysis

AMLX$30.29+0.43 +1.44%
BiotechnologyGrowth Stock
Compare
Market cap$3.89BEnterprise value$3.66BRevenue (TTM)$0Market position—

Score

66
Bullish
Value
49
Quality
48
Growth
100

AI Analysis

Snapshot

Amylyx Pharmaceuticals doesn’t screen as a clean setup today — Stocklytics 66/100 leaves more to prove. Under the hood: revenue compounding ~479% annually over recent years.

Price History

Bullish (65+)Neutral (45–64)Bearish (<45)

Score Breakdown

Market percentile scores loading…

Value

49
PE Ratio (F)–
PEG Ratio–
Free Cashflow Yield %–
EV/EBITDA Ratio–
Discount vs All Time Peak–
Discount vs 1Y Peak–

Growth

100
Earnings Forecast–
Last 3M Earnings Growth %–
12M Revenue Growth %–
12M Earnings Growth %–
5 YR CAGR % Earnings–
Analyst Price Forecast–

Quality

48
FCF Margin %–
Net Debt / EBITDA–
Operating Margin %–
Operating Margin Growth %–
ROCE %–
Current Ratio–

Financial Summary

Amylyx Pharmaceuticals, Inc. (AMLX) last printed $30.29. Equity value is $3.89B. Trailing earnings multiple —. The revenue row is reported history. Targets and ratings are on the forecast page.

Financials

2019202020212022202320242025
$1.43M$650,000.00$0.00$22.23M$380.79M$87.37M$0.00

About

Amylyx Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm, primarily focused on creating therapies for amyotrophic lateral sclerosis (ALS) and various other neurodegenerative conditions. A key asset in its developmental pipeline is AMX0035, a proprietary dual UPR-Bax apoptosis inhibitor. This compound, which integrates sodium phenylbutyrate and taurursodiol, is under investigation for treating ALS, and its application is also being explored for other neurodegenerative diseases. The company was established in 2013 and is based in Cambridge, Massachusetts.

Amylyx Pharmaceuticals (AMLX) Stock Price & Analysis

AMLX price $30.29 +0.43 +1.44%

Ticker
AMLX
Price
$30.29
Change
+0.43 +1.44%
Market cap
$3.89B
Forward P/E
12.28
Dividend yield
0.00%
Beta
-0.20
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
66
Value
49
Quality
48
Growth
100

Stocklytics score rationale: value 49, quality 48, growth 100.

Fair value

AMLX fair value $62.74. Price $30.29. Price is 52% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price.

Fair value is the earnings value from next-twelve-months EPS times 28.4, a blend of the industry median and the stock's own 10-year median. A cash-flow value is not available for this stock. How we calculate it →

Compare AMLX

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2027-03-02—-0.36—12.00K
2026-11-05-0.38-0.38—59.43K
2026-08-06-0.39-0.36——
2026-05-07-0.37-0.34——
2026-03-03-0.30-0.31—-52.00K
2025-11-06-0.37-0.43—52.00K
2025-08-07-0.46-0.44——
2025-05-08-0.42-0.45——
2025-03-04-0.55-0.49665.00K—
2024-11-07-1.07-0.60416.00K31.57M
2024-08-08-0.73-0.381.02M10.66M
2024-05-10-0.46-0.0088.60M98.35M
2024-02-220.070.23108.45M106.96M
2023-11-090.300.44102.69M107.85M
2023-08-100.310.1098.22M92.11M
2023-05-110.02-0.2471.43M87.61M
2023-03-13-0.65-0.7721.89M58.99M
2022-11-10-0.92-0.97345.00K83.33K
2022-08-11-0.93-0.92—125.00K
2022-05-12-0.93-0.75—83.33K
2022-03-30-4.15-0.64——
2022-01-10-0.42—285.00K—
2021-06-30-0.48———
2021-03-31-0.32———
2020-12-31-0.19—350.00K—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency Quarterly.

Safety score 43/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. Dividend history is short. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
2018-03-28$0.42—2018-04-02Quarterly
2017-12-28$0.36—2018-01-02Quarterly
2017-09-28$0.24—2017-10-02Quarterly

Insider trades

DateInsiderActionSharesPriceValue
2026-11-10FRATES JAMES MSell20.00K$6.88137.60K
2026-11-10FRATES JAMES MBuy20.00K$6.88137.60K
2026-11-10FRATES JAMES MSell12.80K$30.32388.11K
2026-11-10FRATES JAMES MSell7.20K$30.97222.98K
2026-11-09FRATES JAMES MSell20.00K$6.88137.60K
2026-11-09FRATES JAMES MSell7.70K$29.39226.29K
2026-11-09FRATES JAMES MSell12.30K$30.11370.36K
2026-11-09Klee Justin B.Sell37.48K$29.391.10M
2026-11-09Klee Justin B.Sell62.52K$30.111.88M
2026-11-09Cohen Joshua BSell38.10K$29.391.12M
2026-11-09Cohen Joshua BSell61.90K$30.111.86M
2026-10-05MILNE GEORGE M JRSell30.00K$27.70830.90K
2026-09-10Bedrosian Camille LSell7.95K$32.21256.00K
2026-09-10Bedrosian Camille LSell2.08K$33.0968.86K
2026-09-10FRATES JAMES MSell9.77K$32.27315.19K
2026-09-10FRATES JAMES MSell1.04K$33.2334.63K
2026-09-10Mazzariello GinaSell9.53K$32.46309.14K
2026-09-10Mazzariello GinaSell11$33.34367
2026-09-10Klee Justin B.Sell29.02K$32.13932.55K
2026-09-10Klee Justin B.Sell1.44K$33.1647.71K
2026-09-10Cohen Joshua BSell29.55K$32.16950.04K
2026-09-10Cohen Joshua BSell919$33.1530.46K
2026-08-31Firestone KarenBuy25.00K$5.05126.25K
2026-08-31Firestone KarenBuy25.00K$1.7644.00K
2026-08-31Firestone KarenSell25.00K$1.7644.00K
2026-08-31Firestone KarenSell25.00K$5.05126.25K
2026-08-18FRATES JAMES MBuy22.81K——
2026-08-18Klee Justin B.Buy60.04K——
2026-08-18Mazzariello GinaBuy21.28K——
2026-08-18Bedrosian Camille LBuy22.81K——
2026-08-18Cohen Joshua BBuy60.04K——
2026-07-10Mazzariello GinaSell15.00K$17.61264.12K
2026-07-09Mazzariello GinaSell15.00K$18.32274.75K
2026-06-04Zeiher Bernhardt GBuy24.37K$14.31348.76K
2026-06-04Firestone KarenBuy24.37K$14.31348.76K
2026-06-04Quimi DaphneBuy24.37K$14.31348.76K
2026-06-04MILNE GEORGE M JRBuy24.37K$14.31348.76K
2026-06-04FONTEYNE PAUL R.Buy24.37K$14.31348.76K
2026-05-21Firestone KarenBuy3.80K$13.5151.34K
2026-03-05Cohen Joshua BBuy248.87K——
2026-03-05Cohen Joshua BBuy373.30K$14.105.26M
2026-03-05Mazzariello GinaBuy74.66K——
2026-03-05Mazzariello GinaBuy111.99K$14.101.58M
2026-03-05FRATES JAMES MBuy95.99K——
2026-03-05FRATES JAMES MBuy143.99K$14.102.03M
2026-03-05Klee Justin B.Buy248.87K——
2026-03-05Klee Justin B.Buy373.30K$14.105.26M
2026-03-05Bedrosian Camille LBuy95.99K——
2026-03-05Bedrosian Camille LBuy143.99K$14.102.03M
2026-03-02Klee Justin B.Sell29.28K$14.47423.76K
2026-03-02Cohen Joshua BSell29.28K$14.48424.12K
2026-03-02Bedrosian Camille LSell6.46K$14.5894.21K
2026-03-02FRATES JAMES MSell7.91K$14.52114.85K
2026-03-02Mazzariello GinaSell6.84K$14.5299.38K
2026-02-23Mazzariello GinaSell3.42K$14.1448.35K
2026-02-02FRATES JAMES MSell3.56K$14.6552.10K
2026-02-02Cohen Joshua BSell15.50K$14.68227.59K
2026-02-02Mazzariello GinaSell3.45K$14.6550.52K
2026-02-02Klee Justin B.Sell15.50K$14.69227.62K
2026-01-16Cohen Joshua BBuy2.82K$7.5721.33K
2026-01-16Cohen Joshua BSell1.97K$13.8327.30K
2026-01-16Cohen Joshua BSell2.82K$7.5721.33K
2026-01-16Klee Justin B.Buy2.85K$7.5721.55K
2026-01-16Klee Justin B.Sell2.00K$13.8927.70K
2026-01-16Klee Justin B.Sell2.85K$7.5721.55K
2026-01-15Cohen Joshua BBuy197.18K$7.571.49M
2026-01-15Cohen Joshua BSell136.19K$13.591.85M
2026-01-15Cohen Joshua BSell197.18K$7.571.49M
2026-01-15Klee Justin B.Buy197.15K$7.571.49M
2026-01-15Klee Justin B.Sell136.19K$13.581.85M
2026-01-15Klee Justin B.Sell197.15K$7.571.49M
2026-01-12MILNE GEORGE M JRSell17.78K——
2026-01-06FRATES JAMES MSell3.33K$11.1136.95K
2026-01-06Cohen Joshua BSell7.71K$11.0985.60K
2026-01-06Klee Justin B.Sell7.71K$11.0985.59K
2025-12-23Firestone KarenBuy8.10K$12.45100.84K
2025-12-01Bedrosian Camille LSell6.58K$14.3594.42K
2025-09-30Klee Justin B.Sell29.77K$14.37427.95K
2025-09-30Klee Justin B.Sell200$15.013.00K
2025-09-30Mazzariello GinaSell8.83K$14.58128.67K
2025-09-30FRATES JAMES MSell10.56K$14.65154.65K
2025-09-30Cohen Joshua BSell29.73K$14.34426.47K
2025-09-30Cohen Joshua BSell200$15.003.00K
2025-09-30Bedrosian Camille LSell12.04K$14.58175.52K
2025-08-13Mazzariello GinaSell15.00K$8.34125.05K
2025-08-12Mazzariello GinaSell15.00K$8.07121.10K
2025-06-05FONTEYNE PAUL R.Buy25.00K$5.05126.25K
2025-06-05Firestone KarenBuy25.00K$5.05126.25K
2025-06-05Quimi DaphneBuy25.00K$5.05126.25K
2025-06-05MILNE GEORGE M JRBuy25.00K$5.05126.25K
2025-06-05Zeiher Bernhardt GBuy25.00K$5.05126.25K
2025-05-22Mazzariello GinaSell1.00K——
2025-03-31FRATES JAMES MSell10.90K$3.4737.81K
2025-03-31Bedrosian Camille LSell12.43K$3.4743.08K
2025-03-31Mazzariello GinaSell9.19K$3.4831.95K
2025-03-31Cohen Joshua BSell21.49K$3.4774.48K
2025-03-31Klee Justin B.Sell21.49K$3.4674.45K
2025-03-20Zeiher Bernhardt GBuy10.00K$3.7037.01K
2025-03-06Mazzariello GinaBuy63.85K——
2025-03-06Mazzariello GinaBuy95.78K$3.61345.75K

Institutional holders

Latest filed quarter: Q3 2026.

Institutions holding: 152, holders -71 vs prior quarter. Ownership 58.52%.

HolderSharesChangeChange %Value
FMR LLC19.95M3.22M+19.23%580.41M
BLACKROCK, INC.10.37M1.54M+17.46%301.71M
VANGUARD CAPITAL MANAGEMENT LLC5.08M853.29K+20.20%147.76M
FRANKLIN TEMPLETON INC3.93M981.50K+33.27%115.59M
JPMORGAN CHASE & CO3.43M1.57M+84.29%100.70M
MORGAN STANLEY2.79M-336.54K-10.75%81.31M
STATE STREET CORP2.72M114.33K+4.39%79.08M
GEODE CAPITAL MANAGEMENT, LLC2.66M324.92K+13.91%77.43M
SIREN, L.L.C.2.48M1.00M+67.54%72.19M
VANGUARD PORTFOLIO MANAGEMENT LLC1.18M115.33K+10.86%34.25M
DEUTSCHE BANK AG\1.07M515.78K+92.44%31.25M
VANGUARD FIDUCIARY TRUST CO748.62K125.54K+20.15%21.78M
JANE STREET GROUP, LLC735.23K735.23KNew21.40M
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD.680.50K-40.51K-5.62%19.80M
FEDERATED HERMES, INC.532.76K70.55K+15.26%15.50M
NUVEEN, LLC505.64K505.64KNew14.71M
MARSHALL WACE, LLP377.03K377.03KNew10.97M
FIRST TRUST ADVISORS LP342.03K342.03KNew9.95M
ENSIGN PEAK ADVISORS, INC337.74K337.74KNew9.83M
AFFINITY ASSET ADVISORS, LLC300.00K300.00KNew8.73M
BANK OF NEW YORK MELLON CORP294.20K294.20KNew8.56M
HRT FINANCIAL LP250.79K250.79KNew7.30M
UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH247.08K247.08KNew7.19M
BARCLAYS PLC201.15K201.15KNew5.85M
ALDEBARAN CAPITAL, LLC196.03K196.03KNew5.70M

Insights · Forecast · Financials · Learn

Stocklytics home · Screener